Novel Markers for Detecting Early Progression of Glaucoma

Active, not recruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Glaucoma

Interventions

DIAGNOSTIC_TEST

Optical Coherence tomography angiography

All subjects will have OCT angiography imaging performed

Trial Locations (1)

Eye Care Centre, Halifax

All Listed Sponsors

lead

Balwantray Chauhan

OTHER

NCT03108443 - Novel Markers for Detecting Early Progression of Glaucoma | Biotech Hunter | Biotech Hunter